Cost-utility analysis of interferon-free treatments for patients with early-stage genotype 1 hepatitis C virus in Brazil

Abstract INTRODUCTION We conducted a cost-utility analysis of available interferon-free treatments for patients with early-stage genotype 1 chronic hepatitis C based on a Brazilian public health system perspective. METHODS A Markov model was derived using a cohort of stage F0-F2 patients treated...

Full description

Bibliographic Details
Main Authors: Vinicius Lins Ferreira, Leticia Paula Leonart, Maria Lucia Alves Pedroso, Roberto Pontarolo
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2020-06-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100651&tlng=en